Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis

Archive ouverte

Marchais, Antonin | Marques da Costa, Maria Eugenia | Job, Bastien | Abbas, Rachid | Drubay, Damien | Piperno-Neumann, Sophie | Fromigué, Olivia | Gomez-Brouchet, Anne | Redini, Françoise | Droit, Robin | Lervat, Cyril | Entz-Werle, Natacha | Pacquement, Hélène | Devoldere, Catherine | Cupissol, Didier | Bodet, Damien | Gandemer, Virginie | Berger, Marc | Marec-Berard, Perrine | Jimenez, Marta | Vassal, Gilles | Geoerger, Birgit | Brugières, Laurence | Gaspar, Nathalie

Edité par CCSD ; American Association for Cancer Research -

International audience. Abstract The outcomes of adolescents/young adults with osteosarcoma have not improved in decades. The chaotic karyotype of this rare tumor has precluded the identification of prognostic biomarkers and patient stratification. We reasoned that transcriptomic studies should overcome this genetic complexity. RNA sequencing (RNA-seq) of 79 osteosarcoma diagnostic biopsies identified stable independent components that recapitulate the tumor and microenvironment cell composition. Unsupervised classification of the independent components stratified this cohort into favorable (G1) and unfavorable (G2) prognostic tumors in terms of overall survival. Multivariate survival analysis ranked this stratification as the most influential variable. Functional characterization associated G1 tumors with innate immunity and G2 tumors with angiogenic, osteoclastic, and adipogenic activities as well as PPARγ pathway upregulation. A focused gene signature that predicted G1/G2 tumors from RNA-seq data was developed and validated within an independent cohort of 82 osteosarcomas. This signature was further validated with a custom NanoString panel in 96 additional osteosarcomas. This study thus proposes new biomarkers to detect high-risk patients and new therapeutic options for osteosarcoma. Significance: These findings indicate that the osteosarcoma microenvironment composition is a major feature to identify hard-to-treat patient tumors at diagnosis and define the biological pathways and potential actionable targets associated with these tumors.

Consulter en ligne

Suggestions

Du même auteur

Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models

Archive ouverte | da Costa, Maria, Eugenia Marques | CCSD

International audience. Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models.

Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement

Archive ouverte | Green, Darrell | CCSD

International audience. Abstract Osteosarcoma and Ewing sarcoma are bone tumors mostly diagnosed in children, adolescents, and young adults. Despite multimodal therapy, morbidity is high and survival rates remain lo...

Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study

Archive ouverte | Gaspar, Nathalie | CCSD

International audience. BACKGROUND:In most countries, reference chemotherapy for osteosarcoma is MAP regimen (M = high-dose methotrexate, AP = doxorubicin-cisplatinum). In France, the standard preoperative chemother...

Chargement des enrichissements...